Lista de obras -

Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.

artículo científico publicado en 2016

Bone scintigraphy and secondary osteomalacia due to nephrotoxicity in a chronic hepatitis B patient treated with tenofovir ⬇️

artículo científico publicado el 4 de agosto de 2013

Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

artículo científico publicado en 2016

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

artículo científico publicado en 2017

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

artículo científico publicado en 2016

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

artículo científico publicado en 2017

Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients ⬇️

artículo científico publicado el 1 de mayo de 2012

Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System

artículo científico publicado en 2017

Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C ⬇️

artículo científico publicado el 28 de marzo de 2013

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

artículo científico publicado en 2015

High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.

artículo científico publicado en 2015

High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4.

artículo científico publicado en 2017

High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods

artículo científico publicado en 2015

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

artículo científico publicado en 2014

Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease.

artículo científico publicado en 2013

Increasing Impact of Chronic Viral Hepatitis on Hospital Admissions and Mortality among HIV-Infected Patients ⬇️

artículo científico publicado el 1 de noviembre de 2001

Lack of antiretroviral effect of alpha-interferon in HIV-infected patients treated for chronic hepatitis C ⬇️

artículo científico publicado el 1 de noviembre de 1997

Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia

artículo científico publicado en 2019

Management of hepatitis C in HIV-infected persons ⬇️

artículo científico publicado el 1 de noviembre de 2001

Meta‐analysis: pegylated interferon α‐2a achieves higher early virological responses than α‐2b in chronic hepatitis C ⬇️

artículo científico publicado el 14 de abril de 2013

Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain

artículo científico publicado en 2013

Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

artículo científico publicado en 2017

Strategies to manage hepatitis C virus (HCV) disease burden.

artículo científico publicado en 2014

The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity

scientific article published on 23 October 2018

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

artículo científico publicado en 2014

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.

artículo científico publicado en 2017

Lista de obras de

Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.

Bone scintigraphy and secondary osteomalacia due to nephrotoxicity in a chronic hepatitis B patient treated with tenofovir ⬇️

Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients ⬇️

Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System

Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C ⬇️

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.

High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4.

High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease.

Increasing Impact of Chronic Viral Hepatitis on Hospital Admissions and Mortality among HIV-Infected Patients ⬇️

Lack of antiretroviral effect of alpha-interferon in HIV-infected patients treated for chronic hepatitis C ⬇️

Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia

Management of hepatitis C in HIV-infected persons ⬇️

Meta‐analysis: pegylated interferon α‐2a achieves higher early virological responses than α‐2b in chronic hepatitis C ⬇️

Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain

Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

Strategies to manage hepatitis C virus (HCV) disease burden.

The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.